All Stories

  1. Validation of drug‐nondrug choice procedure to model maladaptive behavioural allocation to opioid use in rats

    Article • Addiction Biology, October 2024, Wiley

    Esmail Riahi

  2. Restoring the firing activity of ventral tegmental area neurons by lateral hypothalamic deep brain stimulation following morphine administration in rats

    Article • Physiology & Behavior, August 2023, Elsevier

    Esmail Riahi

  3. Deep brain stimulation of the lateral hypothalamus to block morphine reward: Does the intensity of stimulation matter?

    Article • Behavioural Brain Research, February 2023, Elsevier

    Esmail Riahi

  4. Deep Brain Stimulation of the Lateral Hypothalamus Facilitates Extinction and Prevents Reinstatement of Morphine Place Preference in Rats

    Article • Neuromodulation Technology at the Neural Interface, February 2021, Elsevier

    Esmail Riahi

  5. GnRH protective effects against amyloid β-induced cognitive decline: A potential role of the 17β-estradiol

    Article • Molecular and Cellular Endocrinology, December 2020, Elsevier

    Esmail Riahi

  6. Inhibition of brain 17β-estradiol synthesis by letrozole induces cognitive decline in male and female rats

    Article • Neurobiology of Learning and Memory, November 2020, Elsevier

    Esmail Riahi

  7. The potential role of the orexin reward system in future treatments for opioid drug abuse

    Article • Brain Research, March 2020, Elsevier

    Esmail Riahi

  8. Deep brain stimulation of the orbitofrontal cortex prevents the development and reinstatement of morphine place preference

    Article • Addiction Biology, June 2019, Wiley

    Esmail Riahi

  9. Preventing morphine reinforcement with high‐frequency deep brain stimulation of the lateral hypothalamic area

    Article • Addiction Biology, May 2018, Wiley

    Esmail Riahi

  10. The incidence of traumatic brain injury in Tehran, Iran

    Article • Brain Injury, February 2018, Taylor & Francis

    Esmail Riahi

  11. Does High-Frequency Deep Brain Stimulation in Dorsal Regions of the Ventral Striatum Impair Extinction of Morphine-Induced Place Preference?

    Article • Biological Psychiatry, January 2018, Elsevier

    Esmail Riahi

  12. Minocycline increases firing rates of accumbal neurons and modifies the effects of morphine on neuronal activity

    Article • Addiction Biology, September 2017, Wiley

    Reza Arezoomandan, Esmail Riahi

  13. Reply to Li, Xing‐Huan and Zuo, Yun‐Xia, regarding their comment ‘Correspondence letter to the editor regarding “early childhood exposure to short periods of sevoflurane is not associated with later, lasting cognitive deficits”’

    Article • Pediatric Anesthesia, March 2017, Wiley

    Esmail Riahi

  14. Early childhood exposure to short periods of sevoflurane is not associated with later, lasting cognitive deficits

    Article • Pediatric Anesthesia, July 2016, Wiley

    Esmail Riahi

  15. The electrical activity of hippocampal pyramidal neuron is subjected to descending control by the brain orexin/hypocretin system

    Article • Neurobiology of Learning and Memory, March 2015, Elsevier

    Esmail Riahi

  16. Non-Invasive Histologic Markers of Liver Disease in Patients With Chronic Hepatitis B

    Article • Hepatitis Monthly, February 2014, Kowsar Medical Institute

    Esmail Riahi

  17. Powerful inhibitory action of mu opioid receptors (MOR) on cholinergic interneuron excitability in the dorsal striatum

    Article • Neuropharmacology, December 2013, Elsevier

    Paola Bonsi, Esmail Riahi

  18. Role of dorsal hippocampal orexin-1 receptors in associating morphine reward with contextual stimuli

    Article • Behavioural Pharmacology, August 2013, Wolters Kluwer Health

    Esmail Riahi

  19. Orexin A in the ventral tegmental area induces conditioned place preference in a dose-dependent manner: Involvement of D1/D2 receptors in the nucleus accumbens

    Article • Peptides, October 2012, Elsevier

    Professor Abbas Ali - Vafaei, Esmail Riahi

  20. Salivary high‐sensitivity cardiac troponin T levels in patients with acute myocardial infarction

    Article • Oral Diseases, July 2012, Wiley

    Professor Iraj Mirzaii-Dizgah, Esmail Riahi

  21. Corrigendum to ‘Attenuation of morphine withdrawal signs by a GABAB receptor agonist in the locus coeruleus of rats’ [Behav. Brain Res. 196 (January (1)) (2009) 11–14]

    Article • Behavioural Brain Research, September 2011, Elsevier

    Esmail Riahi

  22. Saliva-based creatine kinase MB measurement as a potential point-of-care testing for detection of myocardial infarction

    Article • Clinical Oral Investigations, June 2011, Springer Science + Business Media

    Esmail Riahi

  23. Serum and Saliva Levels of Cathepsin L in Patients with Acute Coronary Syndrome

    Article • The Journal of Contemporary Dental Practice, January 2011, Jaypee Brothers Medical Publishing

    Esmail Riahi

  24. Attenuation of morphine withdrawal signs by a GABAB receptor agonist in the locus coeruleus of rats

    Article • Behavioural Brain Research, January 2009, Elsevier

    Esmail Riahi

  25. Attenuation of morphine withdrawal signs by muscimol in the locus coeruleus of rats

    Article • Behavioural Pharmacology, May 2008, Wolters Kluwer Health

    Dr Morteza Karimian, Esmail Riahi